IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye injection PRO-169 enters safety trial for Diabetes-Related vision loss
Disease control Not yet recruitingThis Phase 1 trial will test the safety of PRO-169, a form of bevacizumab injected into the eye, in 60 adults with diabetic macular edema. The study checks for immune reactions and side effects. It is not yet recruiting and focuses on safety, not whether it improves vision.
Matched conditions: IMMUNOGENICITY
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
One shot to prevent cancer: new HPV vaccine tested in zambia
Prevention Not yet recruitingThis study tests whether a single dose of the CERVAVAC HPV vaccine works as well as a single dose of Gardasil in preventing HPV infection. About 1,266 girls, boys, and young women in Zambia will receive one shot of either vaccine. Researchers will check their immune response at 6…
Matched conditions: IMMUNOGENICITY
Phase: PHASE4 • Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Jun 22, 2026 11:57 UTC